top of page
In a Meeting

CONSULTING

Projects

Torskal: Pioneering Green Nanomedicine for Cancer Therapy

Image by Louis Reed

Torskal is an innovative French biotech company specializing in non-ionizing plasmonic photothermal therapy (PTT) for oncology. Headquartered in La Réunion, France, Torskal is redefining cancer treatment through a sustainable, highly targeted approach that leverages green-synthesized gold nanoparticles derived from plant extracts.

​

The company’s lead program, TSK-001, targets nodular basal-cell carcinoma (BCC)—the most common form of skin cancer. By harnessing a novel PTT mechanism, TSK-001 uses near-infrared light to activate tumor-accumulated nanoparticles, generating localized heat that eradicates malignant cells while sparing healthy tissue. This non-invasive, non-toxic modality offers patients a precision alternative to radiation or chemotherapy.

​

What truly sets Torskal apart is its end-to-end “green nanotechnology” platform. Its gold nanoparticles are produced via an eco-friendly, plant-based synthesis—entirely free of hazardous reagents and fully compliant with European sustainability directives—resulting in superior biocompatibility and minimal environmental footprint.

​

Founded and led by Dr. Anne-Laure Morel—who holds a PhD in Physical Chemistry of Materials from the University Pierre et Marie Curie (UPMC) and a Master’s in Structural Biochemistry from the University of Bordeaux—Torskal benefits from her decade-long expertise in green nanochemistry and molecular diagnostics. Under her leadership, the company’s core patent family—including the “Green Synthesis of Nanogold Particles and Ecological Manufacturing Method” and associated compositions and applications in oncology and dermocosmetics—has been granted in over 40 countries, with a flagship patent authorized in 45 jurisdictions​.

​

Supported by top-tier clinical and academic partners across France and Europe, Torskal is presently preparing for a combined Phase 1–2 clinical trial to evaluate the safety and efficacy of TSK-001 in human patients—bringing the promise of truly green, precision photothermal cancer therapy ever closer to reality.

Services

International Investment and Financing Services:

  • Angel and Early-Stage investments

  • International incubation with equity holdings

  • Financing consulting

  • Investment matchmaking activities

  • Industrial Park connection services

International Market Access Consulting Services:

  • FDA agency services

  • International standard testing

  • QSR/cGMP declaration for medical device products

  • Medical device registration and clinical evaluation

Market Promotion and Sales:

  • Promotion and sales of biopharmaceutical and medical device products in North American and Asian markets

  • Establishment of a global online sales system

  • Operation of warehousing and logistics services in North America and Asia

Production Outsourcing and Global Procurement Services:

  • Process research and validation for products

  • Original equipment manufacturing for pilot and post-market stages of products.

  • Procurement and customized procurement services for medical devices and research experimental products.

bottom of page